BMC Cancer Oncology

Proclarix’ performance in ruling out patients with no or indolent prostate cancer: evaluation in a Danish population

Ralph Schiess, Alcibiade Athanasiou, Madlen M.E. Kasten, Torben F Hansen, Gitte E Kissow, Louise F Obro, Jonna S Madsen, Mads H Poulsen, Palle J Osther, Ahmed H. Zedan
Springer Nature · 2026-05-09 · DOI 10.1186/s12885-026-16118-8

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →